Language use may predict Alzheimer's
Posted on: Friday, 10 July 2009, 22:10 CDT
Alzheimer's disease may be less likely in those who had good language skills when college age, U.S researchers say.
The study, published in Neurology, was based on participants in the Nun Study -- an ongoing clinical study of Alzheimer's disease risk factors in members of the School Sisters of Notre Dame congregation living in the United States.
Study author Dr. Juan Troncoso of Johns Hopkins University in Baltimore says essays from 14 participants written as they entered the convent in their late teens or early 20s were scored on language -- on the number of ideas per 10 words -- and grammar complexity.
The language scores were 20 percent higher in the women without memory problems. The grammar score did not show any difference between the two groups.
Our results show that an intellectual ability test in the early 20s may predict the likelihood of remaining cognitively normal five or six decades later, even in the presence of a large amount of Alzheimer's disease pathology,
Troncoso says in a statement.
Source: United Press International
Related Articles
- Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimer's Disease
- First Ever Study on Alzheimer's Disease Treatment in Hispanics Presented at Major Medical Meeting
- Accera, Inc. Announces Open-Label Data From Phase II Study in Alzheimer's Disease at International Conference on Prevention of Dementia
- Accera, Inc. To Present Results of Phase II Study in Alzheimer's Disease at American Academy of Neurology Meeting
- Sarasota's Roskamp Institute Announces Positive Safety Data in Human Clinical Study for Alzheimer's Disease
- The Expected Toxicity Rate at the Maximum Tolerated Dose in Bridging Studies in Alzheimer's Disease
- New Study Finds Evidence That Taking a Statin Drug Can Help Treat Alzheimer's Disease
- Phytopharm Announces Results of Interim Data Review for Phase II Proof of Principle Study in Alzheimer's Disease
- Long-Term Effects of Rivastigmine Treatment on Neuropsychiatric and Behavioral Disturbances in Nursing Home Residents With Moderate to Severe Alzheimer's Disease: Results of a 52-Week Open-Label Study
- ExonHit Therapeutics Accelerates Its Clinical Development Programme in Alzheimer's Disease
User Comments (0)

RSS Feeds